Showing 121 - 140 results of 448 for search '"monoclonal antibody"', query time: 0.07s Refine Results
  1. 121

    Usefulness of Immunological Detection of the Human Telomerase Reverse Transcriptase by Annalisa Volpi, Sara Bravaccini, Laura Medri, Serenella Cerasoli, Michele Gaudio, Dino Amadori

    Published 2005-01-01
    “…Conclusions: Immunohistochemistry with a well characterised hTERT-specific monoclonal antibody permitted the identification of hTERT immunopositive cells in normal somatic tissues. …”
    Get full text
    Article
  2. 122

    Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma by Gorkem Odabas, Metin Cetin, Serdar Turhal, Huseyin Baloglu, A. Emre Sayan, Tamer Yagci

    Published 2018-01-01
    “…In vivo evaluation of Plexin C1 expression in HCC tissues was accomplished by immunohistochemistry studies in tissue microarrays. Results. A monoclonal antibody, clone PE4, specific to Plexin C1, was generated. …”
    Get full text
    Article
  3. 123

    A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab by Behdod Poushanchi, Hiren Vallabh, Gorman Joel Reynolds

    Published 2018-01-01
    “…Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. …”
    Get full text
    Article
  4. 124

    Ocrelizumab-Induced Severe Colitis by Hsing Hwa Lee, Naveen Sritharan, Daniel Bermingham, Gabriela Strey

    Published 2020-01-01
    “…We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. …”
    Get full text
    Article
  5. 125

    The Safety of Infliximab Infusions in the Community Setting by James Ducharme, Cindy Pelletier, Ramesh Zacharias

    Published 2010-01-01
    “…Infliximab, a chimeric anti-TNFα monoclonal antibody, has been shown to reduce the severity of symptoms or induces remission of active disease. …”
    Get full text
    Article
  6. 126

    Interstitial Granulomatous Drug Reaction to Ustekinumab by A. Walker, J. S. Westerdahl, J. Zussman, J. Mathis

    Published 2022-01-01
    “…Ustekinumab is a human monoclonal antibody that targets inflammatory cytokines IL-12 and IL-23 and has been have shown to be effective in treating IGDR. …”
    Get full text
    Article
  7. 127

    The Link between Allergic Rhinitis and Asthma: A Role for Antileukotrienes? by H Kim, J Bouchard, PM Renzix

    Published 2008-01-01
    “…However, each disorder has an array of treatments used separately in controlling these atopic disorders, from inhaled corticosteroids, beta2-agonists and antihistamines to newer monoclonal antibody-based treatments. The present article reviews the shared components of allergic rhinitis and asthma, and examines recent evidence supporting antileukotrienes as effective agents in reducing the symptoms of both diseases.…”
    Get full text
    Article
  8. 128

    Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies by Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das

    Published 2023-10-01
    “…., remdesivir), and monoclonal antibody-based immunomodulation (e.g., tocilizumab). …”
    Get full text
    Article
  9. 129

    Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass by Reuben J. Arasaratnam, Alejandro Restrepo

    Published 2017-01-01
    “…The patient was treated successfully with immunosuppression reduction, anti-CD20 monoclonal antibody therapy, and cytotoxic chemotherapy. …”
    Get full text
    Article
  10. 130

    Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma? by Gérald E. Piérard, François Aubin, Philippe Humbert

    Published 2012-01-01
    “…Immunotherapy is another targeted option. Ipilimumab, a monoclonal antibody directed to CTLA-4 present on cytotoxic T cells boosts immunity, particularly its anti-MM activity. …”
    Get full text
    Article
  11. 131

    A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab by Ted George Achufusi, Prateek S. Harnee, Sekou Rawlins

    Published 2019-01-01
    “…Secukinumab is an IgG monoclonal antibody widely used for treatment of ankylosing spondylitis, psoriasis, and psoriatic arthritis. …”
    Get full text
    Article
  12. 132

    Psoriatic arthritis: An up to date overview by Simon Hackett, Laura Coates

    Published 2020-01-01
    “…In addition to classification, treatment options for PsA have continued to expand over recent years, with the development of monoclonal antibody therapies targeting the underlying immunological mediators involved in PsA such as interleukin (IL)-17, tumor necrosis factor-alpha, and IL-23. …”
    Get full text
    Article
  13. 133

    Involvement of the Dectin-1 Receptor upon the Effector Mechanisms of Human Phagocytic Cells against Paracoccidioides brasiliensis by Juliana Carvalho de Quaglia e Silva, Amanda Manoel Della Coletta, Taiane Priscila Gardizani, Graziela Gorete Romagnoli, Ramon Kaneno, Luciane Alarcão Dias-Melicio

    Published 2019-01-01
    “…However, when cultures were treated with an anti-Dectin-1 monoclonal antibody, to block the P. brasiliensis binding, a decrease in H2O2 production and an increase in fungal recovery were detected. …”
    Get full text
    Article
  14. 134

    A Case of Childhood Severe Paroxysmal Cold Hemoglobinuria with Acute Renal Failure Successfully Treated with Plasma Exchange and Eculizumab by Jessica Pelletier, Chad Ward, Matthew Borloz, Anne Ickes, Susan Guelich, Erwood Edwards

    Published 2022-01-01
    “…She was successfully treated with plasma exchange and eculizumab, a humanized monoclonal antibody targeting complement protein C5, and demonstrated significant improvement of hemolysis and recovery of renal function.…”
    Get full text
    Article
  15. 135

    Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis by Bayanne Olabi, Shanti Ayob

    Published 2020-01-01
    “…Ustekinumab is a monoclonal antibody that targets interleukin-12/23 used in the treatment of moderate-to-severe psoriasis. …”
    Get full text
    Article
  16. 136

    A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity by Sylvana Hidalgo, Carol A. Albright, Gretchen L. Wells

    Published 2013-01-01
    “…Trastuzumab is a monoclonal antibody highly effective in the treatment of several cancers, but its use is associated with cardiac toxicity which usually responds to cessation of the drug and/or medical therapy. …”
    Get full text
    Article
  17. 137

    A Case of Fulminant Meningococcemia: It Is All in the Complement by Kellie L. Hawkins, Mariah Hoffman, Sonia Okuyama, Sarah E. Rowan

    Published 2017-01-01
    “…Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). …”
    Get full text
    Article
  18. 138

    The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma by Evelyn M. Slaughter, Nathan Boyer, Steven Bennett

    Published 2014-01-01
    “…This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. …”
    Get full text
    Article
  19. 139

    Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia by Grzegorz Porebski, Alicja Dziadowiec

    Published 2024-02-01
    “…In this report, we describe a patient with a delayed cutaneous hypersensitivity reaction to evolocumab, a human monoclonal antibody directed against the serine protease proprotein convertase subtilisin/kexin type 9 used to reduce low-density lipoprotein concentrations in the treatment of familial hypercholesterolaemia. …”
    Get full text
    Article
  20. 140

    Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: A case report by Katrina D Cirone, Fiona E Lovegrove

    Published 2025-02-01
    “…Dupilumab, a monoclonal antibody that targets interleukin-4 and interleukin-13, is one of the approved biologic treatments for moderate-to-severe atopic dermatitis. …”
    Get full text
    Article